Side Effects of auranofin: A Synthesis of Findings from 23 Studies
- Home
- Side Effects of auranofin
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of auranofin: A Synthesis of Findings from 23 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
Auranofin is a gold-containing compound that has been used to treat rheumatoid arthritis, and it has recently shown promise as an anticancer agent. Studies have shown that auranofin can effectively inhibit the growth of cancer cells, particularly in cases of acute lymphoblastic leukemia. 5 Its mechanism of action involves disrupting the balance of reactive oxygen species within cancer cells, leading to their destruction. 5
The research on auranofin has also focused on its ability to target specific cells, which is essential for reducing side effects. Researchers have been developing ways to deliver auranofin specifically to cancer cells, thereby minimizing damage to healthy cells. 4
Several studies have investigated the effectiveness of auranofin in treating various diseases. For example, a study on desmoid-type fibromatosis (DF) found that auranofin effectively inhibits the progression of this condition, making it a potential treatment option. 3
Reasons for Side Effects
The side effects of auranofin are often attributed to its interaction with the thioredoxin reductase (TrxR) system, an essential component of the antioxidant defense system in many cells. 13 Auranofin's inhibition of TrxR can lead to an imbalance in reactive oxygen species, causing oxidative stress and cell death. 13 Additionally, auranofin can disrupt intracellular calcium homeostasis, leading to platelet necrosis and other undesirable effects. 13
Common Side Effects
Diarrhea
Auranofin is known to cause gastrointestinal side effects, including diarrhea. This effect can be particularly prominent in the early stages of treatment but tends to lessen over time. 1 The incidence of diarrhea can be as high as 50% in patients starting auranofin treatment. 1
Thrombocytopenia
One of the significant side effects of auranofin is a decrease in platelet count, also known as thrombocytopenia. This reduction in platelets can increase the risk of bleeding. 13 This side effect is associated with auranofin's disruption of intracellular calcium homeostasis and its potential to cause platelet necrosis. 13
Cardiotoxicity
While auranofin is generally well-tolerated, some studies have reported potential cardiotoxicity, particularly at higher doses or with prolonged use. 11 Further research is needed to fully understand the cardiovascular implications of auranofin treatment.
Skin Reactions
Auranofin can sometimes cause allergic reactions in the skin, manifesting as rash or itching. 20 This is more common in patients with a pre-existing allergy to gold. 20
Countermeasures for Side Effects
Diarrhea
For patients experiencing diarrhea, it is crucial to stay hydrated and consider antidiarrheal medications if necessary. 1
Thrombocytopenia
Regular blood tests are essential to monitor platelet count during auranofin treatment. If thrombocytopenia develops, auranofin dosage may need to be adjusted or discontinued. 13
Cardiotoxicity
Regular cardiac monitoring is recommended during auranofin treatment, especially with higher doses or prolonged use. If any cardiovascular abnormalities arise, the treatment plan needs to be reassessed. 11
Skin Reactions
If skin reactions occur, it is essential to contact a healthcare professional. The treatment may need to be adjusted, or alternative medications may be considered. 20
Comparison of Research
Commonalities in Research
Most studies agree that auranofin can be effective in treating various conditions, including rheumatoid arthritis and certain types of cancer. Auranofin has also been consistently linked to side effects such as diarrhea and thrombocytopenia.
Differences in Research
The research on auranofin's cardiotoxicity is somewhat inconsistent. Some studies have suggested a potential for cardiotoxicity, while others have not observed this effect. 11 Further research is necessary to better understand the cardiovascular implications of auranofin.
Points to Note Regarding Application in Real Life
Auranofin is a powerful medication that should only be used under the supervision of a healthcare professional. It is essential to inform your doctor about any pre-existing health conditions or allergies, particularly to gold. It is crucial to avoid self-medication and to report any side effects promptly to your doctor.
Limitations of Current Research
While auranofin shows promise in treating various conditions, further research is needed to fully understand its long-term effects and potential side effects. The cardiotoxicity of auranofin requires further investigation to determine its prevalence and severity.
Future Research Directions
Future research should aim to develop safer and more targeted delivery methods for auranofin, potentially minimizing side effects and maximizing therapeutic efficacy. Further investigation into auranofin's cardiotoxicity and its long-term effects is crucial for ensuring its safe and effective use.
Conclusion
Auranofin is a promising therapeutic agent with potential for treating rheumatoid arthritis, certain cancers, and other conditions. However, it is important to be aware of its side effects, including diarrhea, thrombocytopenia, and potential cardiotoxicity. Close monitoring and communication with your doctor are essential when using auranofin.
Benefit Keywords
Risk Keywords
Article Type
Author: van BeusekomH J, van de LaarM A, FranssenM J, van ValburgJ A, GijzelW P, CouvéeJ E
Language : English
Author: FurstD E
Language : English
Author: ItoKan, NishidaYoshihiro, HamadaShunsuke, ShimizuKoki, SakaiTomohisa, OhkawaraBisei, AlmanBenjamin A, EnomotoAtsushi, IkutaKunihiro, KoikeHiroshi, ZhangJiarui, OhnoKinji, ImagamaShiro
Language : English
Author: MachadoJoão Franco, CorreiaJoão D G, MoraisTânia S
Language : English
Author: KarsaMawar, KosciolekAngelika, BongersAngelika, MarianaAnna, FailesTim, GiffordAndrew J, KeesUrsula R, CheungLaurence C, KotechaRishi S, ArndtGreg M, HaberMichelle, NorrisMurray D, SuttonRosemary, LockRichard B, HendersonMichelle J, SomersKlaartje
Language : English
Author: TolbatovIogann, CirriDamiano, MarchettiLorella, MarroneAlessandro, ColettiCecilia, ReNazzareno, La MendolaDiego, MessoriLuigi, MarzoTiziano, GabbianiChiara, PratesiAlessandro
Language : English
Author: ProettoMaria T, AlexanderKelsey, MelaimiMohand, BertrandGuy, GianneschiNathan C
Language : English
Author: CapperMiles S, PackmanHollie, RehkämperMark
Language : English
Author: EpsteinTessa D, WuBin, MoultonKaren D, YanMingdi, DubeDanielle H
Language : English
Author: HatemElie, AzziSandy, El BannaNadine, HeTiantian, Heneman-MasurelAmélie, VernisLaurence, BaïlleDorothée, MassonVanessa, DingliFlorent, LoewDamarys, AzzaroneBruno, EidPierre, BaldacciGiuseppe, HuangMeng-Er
Language : English
Author: AleksandarPavić, DraganaMitić-Ćulafić, NebojšaJasnić, BiljanaNikolić, NatašaSimin, BrankaVasiljević, JelenaKnežević-Vukčević
Language : English
Author: HatemElie, AzziSandy, El BannaNadine, HeTiantian, Heneman-MasurelAmélie, VernisLaurence, BaïlleDorothée, MassonVanessa, DingliFlorent, LoewDamarys, AzzaroneBruno, EidPierre, BaldacciGiuseppe, HuangMeng-Er
Language : English
Author: HarperMatthew T
Language : English
Author: WarżajtisBeata, GlišićBiljana Đ, SavićNada D, PavicAleksandar, VojnovicSandra, VeselinovićAleksandar, Nikodinovic-RunicJasmina, RychlewskaUrszula, DjuranMiloš I
Language : English
Author: AndradeRosa M, ReedSharon L
Language : English
Author: AlzoubiKousi, EglerJasmin, AbedMajed, LangFlorian
Language : English
Author: TiekinkEdward R T
Language : English
Language : English
Author: DraschG, MussC, RoiderG
Language : English
Author: MöllerH, SvenssonA, BjörknerB, BruzeM, LindrothY, ManthorpeR, TheanderJ
Language : English
Author: RatnaikeR N, JonesT E
Language : English
Author: VlakT, StambukB
Language : Croatian
Author: GordonM M, PorterD R, CapellH A
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.